Donepezilo NORMON 10 mg buccal tablets EFG
Donepezil Hydrochloride
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
1.What Donepezilo NORMON is and what it is used for
2.Before taking Donepezilo NORMON
3.How to take Donepezilo NORMON
4.Possible side effects
5Storage of donepezilo NORMON
6.Additional information
Donepezilo NORMON is a specific and reversible inhibitor of acetylcholinesterase, the predominant cholinesterase in the brain.
It is used for the symptomatic treatment of mild to moderately severe Alzheimer's disease.
- if you are allergic tohydrochloride of donepezilo, to piperidina derivatives or to any of the other components ofthis medication (included in section 6).
Be especially careful with Donepezilo NORMON
Other medications and Donepezilo NORMON
Inform your doctor or pharmacist if you are using, have used recently or may need to use any other medication, even those purchased without a prescription and especially if you are taking any of the following medications:
The consumption of Donepezilo NORMON with alcohol may reduce the absorption of this medication.
Donepezilo NORMON with food and drinks
Place the tablet on the tongue and let it dissolve. Swallow with or without water.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, consult your doctor or pharmacist before using this medication.
Do not take Donepezilo NORMON if you are pregnant.
Do not take Donepezilo NORMON if you are breastfeeding your child.
Driving and operating machinery
Your condition may affect your ability to drive or operate machinery and you should not perform these activities unless your doctor tells you it is safe to do so. Donepezilo NORMON may cause dizziness and drowsiness, mainly at the beginning of treatment or when increasing the dose. If you experience these effects, you should not drive or operate machinery.
Important information about some of the components of Donepezilo NORMON
Lactose:
This medication contains lactose. If your doctor has told you that you have a certain sugar intolerance, consult with him before taking this medication.
Aspartame:
This medication contains 10 mg of aspartame in each buccal tablet.
Aspartame is a source of phenylalanine that may be harmful in the case of phenylketonuria (PKU), a rare genetic disease in which phenylalanine accumulates because the body is unable to eliminate it correctly.
Sodium:
This medication contains less than 23 mg of sodium (1 mmol) per buccal tablet; this is,essentially “sodium-free”.
Follow exactly the administration instructions for this medication as indicated by your doctor. If in doubt, consult your doctor or pharmacist again.
Donepezilo NORMON is administered orally. The tablet should be placed on the tongue and allowed to dissolve before swallowing with or without water.
Treatment with Donepezilo NORMON begins with a 5 mg tablet, taken once a day, at night, immediately before bedtime. After one month of treatment, your doctor may recommend an increase in dosage to 10 mg, taken once a day and at night. The maximum recommended dose is 10 mg/day.
If you experience abnormal dreams, nightmares, or difficulty sleeping (see section 4), your doctor may recommend taking Donepezilo NORMON in the morning.
If you have mild or moderate liver disease (a disease affecting the liver) or kidney disease (a disease affecting the kidney), you can follow a similar dosage schedule as indicated above.
If you take more Donepezilo NORMON than you should
If you have taken more Donepezilo NORMON than you should, consult your doctor, pharmacist, or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount used.
If you forget to take Donepezilo NORMON
Do not take a double dose to compensate for the missed dose.
If you interrupt treatment with Donepezilo NORMON
Do not stop treatment without first consulting your doctor, even if you feel well.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Severe side effects:
Consult your doctor immediately if you experience these severe side effects. You may need urgent medical treatment.
The estimated frequency of these side effects is as follows:
The most frequent side effects that may affect at least 1 in 10 patients are:
The frequent side effects that may affect more than 1 person in 100 but less than 1 in 10 are:
The infrequent side effects that may affect more than 1 person in 1,000 but less than 1 in 100 are:
The rare side effects that may affect less than 1 person in 1,000 are:
The side effects of unknown frequency that cannot be estimated from available data are:
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly to theSpanish System for Pharmacovigilance of Medicines for Human Use:www.notificaRAM.es.By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
This medication does not require special conditions for conservation.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Donepezilo NORMON
Appearance of the product and contents of the package
Donepezilo NORMON is presented in buccal dispersible tablets, i.e., that dissolve in the mouth. The buccal dispersible tablets of Donepezilo NORMON 10 mg are flat, round, with beveled edges and white or off-white in color, embossed with ‘10’ on one face and flat on the other.
Donepezilo NORMON 10 mgis available in PVC/PCTFE (Aclar)/Aluminum blister packs with7, 14, 28, 30, 50, 56, 60, 98, and 120 buccal dispersible tablets.
Only some package sizes may be commercially available.
Holder of the marketing authorization and responsible manufacturer
LABORATORIOS NORMON, S.A.
Ronda de Valdecarrizo, 6 – 28760 Tres Cantos – Madrid (SPAIN)
Last review date of this prospectus: October2022
The detailed information of this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.